SURF
Surface Oncology, Inc.
Set alert
1.07 0.00 0.00%
1.01 Day range 1.09
52-week range unavailable
- Open
- 1.06
- Prev close
- 1.07
- Mkt cap
- 56.86M
- Vol
- 1.46M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.01
- High
- 1.09
- Forward P/E
- -0.79
- Beta
- 1.74
- Short ratio
- 0.33
- Inst. own
- 50.11%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 1, 2023
- 50-d avg
- 0.77176
- 200-d avg
- 0.84846
- 1y target
- 2.38
Financial health
Altman Z-Score
-6.56 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.7×
FY 2016 5y median -1.0× FY 2022
P/S 1.5×
FY 2016 5y median 2.8× FY 2022
P/B 0.5×
FY 2016 5y median 0.9× FY 2022
P/FCF -0.8×
FY 2016 5y median -0.8× FY 2022
EV/EBITDA -0.8×
FY 2016 5y median -0.5× FY 2022
EV/Sales 1.7×
FY 2016 5y median 1.8× FY 2022
FCF Yield -131.3%
FY 2016 5y median -29.5% FY 2022
Profitability
Gross Margin 100.0%
FY 2016 5y median 100.0% FY 2022
Operating Margin -206.2%
FY 2016 5y median -206.2% FY 2022
Net Margin -217.7%
FY 2016 5y median -217.7% FY 2022
ROE -69.9%
FY 2016 5y median -66.8% FY 2022
ROIC -41.4%
FY 2016 5y median -41.4% FY 2022
ROA -40.8%
FY 2016 5y median -40.2% FY 2022
Growth (YoY)
Revenue 1016.5%
FY 2016 FY 2022
Operating Income 18.6%
FY 2016 FY 2022
EPS (diluted) 35.0%
FY 2016 FY 2022
Free Cash Flow 3.9%
FY 2016 FY 2022
Financial Health
Current Ratio 7.9×
FY 2016 5y median 7.9× FY 2022
Quick Ratio 8.0×
FY 2016 5y median 7.9× FY 2022
Debt / Equity 0.6×
FY 2016 5y median 0.4× FY 2022
Net Debt / EBITDA -0.1×
FY 2016 5y median -0.0× FY 2022
Interest Coverage -36.0×
FY 2016 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31